Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12.
Gallardo-Rincón D, Montes-Servín E, Alamilla-García G, Montes-Servín E, Bahena-González A, Cetina-Pérez L, Morales Vásquez F, Cano-Blanco C, Coronel-Martínez J, González-Ibarra E, Espinosa-Romero R, María Alvarez-Gómez R, Pedroza-Torres A, Castro-Eguiluz D. Gallardo-Rincón D, et al. Among authors: bahena gonzalez a. Front Genet. 2022 Jun 6;13:863956. doi: 10.3389/fgene.2022.863956. eCollection 2022. Front Genet. 2022. PMID: 35734436 Free PMC article.
Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients.
Gallardo-Rincón D, Álvarez-Gómez RM, Montes-Servín E, Toledo-Leyva A, Montes-Servín E, Michel-Tello D, Alamilla-García G, Bahena-González A, Hernández-Nava E, Fragoso-Ontiveros V, Espinosa-Romero R, Cetina-Pérez L. Gallardo-Rincón D, et al. Among authors: bahena gonzalez a. Transl Oncol. 2020 Feb;13(2):212-220. doi: 10.1016/j.tranon.2019.11.003. Epub 2019 Dec 20. Transl Oncol. 2020. PMID: 31869745 Free PMC article.
Experiencia con el uso de olaparib en pacientes con cáncer de ovario.
Gallardo-Rincón D, Alamilla-García G, Montes-Servín E, Morales-Vázquez F, Cano-Blanco C, Coronel-Martínez J, Bahena-González A, Gerson-Cwilich R, Isla-Ortiz D, Toledo-Leyva A, Montes-Servín E, Michel-Tello D, Espinosa-Romero R. Gallardo-Rincón D, et al. Among authors: bahena gonzalez a. Gac Med Mex. 2019;155(6):585-589. doi: 10.24875/GMM.19005494. Gac Med Mex. 2019. PMID: 31787769 Free article.
Validation of the Mexican-Spanish Version of the EORTC QLQ-OV28 Instrument for the Assessment of Quality of Life in Women with Ovarian Cancer.
Gallardo-Rincón D, Toledo-Leyva A, Bahena-González A, Montes-Servín E, Muñoz-Montaño W, Coronel-Martínez J, Oñate-Ocaña LF. Gallardo-Rincón D, et al. Among authors: bahena gonzalez a. Arch Med Res. 2020 Oct;51(7):690-699. doi: 10.1016/j.arcmed.2020.07.004. Epub 2020 Aug 5. Arch Med Res. 2020. PMID: 32768148
Recommendations on the pharmacological treatment of epithelial ovarian cancer in Mexico.
Gallardo-Rincón D, Bahena-González A, Álvarez RM, Gómez-García EM, Cortés-Esteban P, Villalobos-Valencia R, Hernández-Hernández CA, Morán-Mendoza AJ, Salcedo-Hernández RA, Cetina-Pérez LDC. Gallardo-Rincón D, et al. Among authors: bahena gonzalez a. Gac Med Mex. 2021 Dec 20;157(M1):1-11. doi: 10.24875/GMM.M21000569. Gac Med Mex. 2021. PMID: 34979533 Free article. English.
Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention.
Pérez-Martín AR, Castro-Eguiluz D, Cetina-Pérez L, Velasco-Torres Y, Bahena-González A, Montes-Servín E, González-Ibarra E, Espinosa-Romero R, Gallardo-Rincón D. Pérez-Martín AR, et al. Among authors: bahena gonzalez a. Bosn J Basic Med Sci. 2022 Jul 29;22(4):499-510. doi: 10.17305/bjbms.2021.6963. Bosn J Basic Med Sci. 2022. PMID: 35276057 Free PMC article. Review.
Validation of the QLQ-EN24 instrument for the assessment of health-related quality of life for women with endometrial cancer in México.
Gallardo-Rincón D, Toledo-Leyva A, Bahena-González A, Montes-Servín E, Pérez-Martín AR, Montes-Servín E, Alamilla-García GC, Carmona-Herrera DD, Coronel-Martínez J, Oñate-Ocaña LF. Gallardo-Rincón D, et al. Among authors: bahena gonzalez a. Arch Gynecol Obstet. 2021 Sep;304(3):773-782. doi: 10.1007/s00404-021-05990-3. Epub 2021 Feb 13. Arch Gynecol Obstet. 2021. PMID: 33582853
Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIs.
Arrieta O, Hernandez-Martinez JM, Montes-Servín E, Heredia D, Cardona AF, Molina-Romero C, Lara-Mejía L, Diaz-Garcia D, Bahena-Gonzalez A, Mendoza-Oliva DL. Arrieta O, et al. Among authors: bahena gonzalez a. Cancer Biomark. 2021;32(2):123-135. doi: 10.3233/CBM-203164. Cancer Biomark. 2021. PMID: 34057135